Minerva Neurosciences Inc (NASDAQ:NERV)
| 9.74 Delayed Data As of 4:00pm ET |  -0.05 / -0.51%Today’s Change | 2.51 Today|||52-Week Range 15.27 | +52.00% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -27.1M | -31.0M | -31.5M | -50.2M | |
| Depreciation | 17.3K | 16.5K | 11.1K | 17.5K | ||
| Total Other Cash Flow | 2.8M | 4.0M | 5.1M | 8.1M | ||
| Funds From Operations | -24.2M | -27.0M | -35.8M | -42.1M | ||
| Funds From/For Other Operating Expenses | 32.0K | -1.3M | -38.9M | -111.0K | ||
| Net Cash Flow - Operating Activities | -24.3M | -25.7M | 3.1M | -41.9M | ||
| Investing | Increase In Investments | -23.3M | 0.00 | -134.5M | -40.7M | |
| Decrease In Investments | 5.0M | 17.8M | 27.4M | 110.2M | ||
| Capital Expenditures | 0.00 | 0.00 | -52.4K | 0.00 | ||
| Net Cash Flow Investing | -18.3M | 17.8M | -107.2M | 69.5M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 9.8M | 0.00 | 0.00 | 0.00 | ||
| Long Term Debt Reduction | 0.00 | -1.6M | -4.9M | -4.0M | ||
| Net Proceeds Stock Sale | 28.5M | 78.1M | 52.1M | 655.9K | ||
| Common Preferred Redeemed | 0.00 | 0.00 | -389.00 | 0.00 | ||
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 38.3M | 76.6M | 47.2M | -3.3M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -4.2M | 68.7M | -56.9M | 24.2M | ||
